Xiuhe Medical Technique

Beijing Xiuhe Medical Technique Co., Ltd. is a diversified biotechnology and medical technology company based in Beijing, China, focused on precision medicine and neuroprotection. The company operates two primary business segments: drug development and advanced diagnostics. In its pharmaceutical division, Xiuhe Medical Technique is developing YC-6 (Androtriol), a novel small molecule neuroprotectant currently in Phase 2 clinical trials for ischemic stroke and intracerebral hemorrhage. In its diagnostics division, the company provides liquid biopsy solutions, including a proprietary circulating tumor cell (CTC) enrichment and identification system for cancer screening and treatment monitoring. By combining therapeutic innovation with precision diagnostics, Xiuhe Medical Technique aims to improve patient outcomes in both oncology and cerebrovascular diseases.